Phase I trial of continuous Taxotere, Adriamycin, and cyclophosphamide with G-CSF (conTAC).

被引：0
|
作者：
Budd, GT [1 ]
Peereboom, D [1 ]
Weiss, P [1 ]
Elson, P [1 ]
机构：
[1] Cleveland Clin Fdn, Ctr Canc, Cleveland, OH 44195 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
354
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [1] Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC Regimen)in advanced malignancies
    Wesolowski, Robert
    Peereboom, David
    Weiss, Patricia
    Elson, Paul
    Budd, George Thomas
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (04) : 502 - 508
  • [2] Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC Regimen)in advanced malignancies
    Robert Wesolowski
    David Peereboom
    Patricia Weiss
    Paul Elson
    George Thomas Budd
    Investigational New Drugs, 2010, 28 : 502 - 508
  • [3] Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial
    Schroeder, Mark A.
    Grillot, Marcus
    Reineck, Teresa
    Jacoby, Meagan A.
    Romee, Rizwan
    Pusic, Iskra
    Welch, John
    Uy, Geoffrey L.
    Cashen, Amanda F.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Kulkarni, Shashikant
    Westervelt, Peter
    Walter, Matthew J.
    Dipersio, John F.
    BLOOD, 2013, 122 (21)
  • [4] Immaturity in neonatal defense: The role of G-CSF in enhancing neonatal immunity - Results of a phase I trial of G-CSF in newborns with presumed sepsis
    Cairo, MS
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL II, PTS 1 AND 2, 1996, : 833 - 837
  • [5] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [6] G-CSF FOLLOWING PULSE CYCLOPHOSPHAMIDE IN SLE
    TESKE, E
    HARTEN, P
    SCHROEDER, JO
    EULER, HH
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S152 - S152
  • [7] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [8] A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes
    Huselton, Eric
    Rettig, Michael P.
    Fletcher, Theresa
    Ritchey, Julie
    Gehrs, Leah
    McFarland, Kyle
    Christ, Stephanie
    Eades, William C.
    Trinkaus, Kathryn
    Romee, Rizwan
    Kulkarni, Shashikant
    Ghobadi, Armin
    Abboud, Camille
    Cashen, Amanda F.
    Stockerl-Goldstein, Keith
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1441 - 1449
  • [9] Are murine leukemogenic cells mobilized by cyclophosphamide and G-CSF?
    Gidali, J
    Feher, I
    SzaboNemedi, N
    Toth, S
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 597 - 597
  • [10] TREATMENT OF REFRACTORY FELTYS SYNDROME WITH G-CSF AND CYCLOPHOSPHAMIDE
    CHOI, V
    MANT, M
    AARON, S
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S340 - S340
12345